A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Chordoma

NCT06787664 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Chordoma

Interventions

DRUG: BL-B01D1

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.

Collaborators

[object Object]